UltraPlus is a multi-application workstation using world renowned and patented Variable Pulsed Light VPL™ technology from Energist Medical Group. This compact and versatile system offers the power and flexibility you need to achieve optimal clinical results for hair removal, skin rejuvenation, vascular applications, pigmented lesions and the treatment of active acne. Specific handpieces for each treatment ensure delivery of the optimal wavelengths to the target chromophore. With fluence up to 108J/cm2 and over 840 pulse delivery variations, you have the flexibility to select the appropriate parameters for every application. UltraPlus offers you the power and flexibility to perform a wide range of efficacious treatments with a single system:
Investing in UltraPlus will enable you to perform a wide range of treatments with a single device, opening untapped revenue streams and enabling rapid return on investment.
The Specialist handpiece, specifically designed for treatment of pigmentation and vascular lesions including telangiectatic matting, PWS, Refractory Rosacea, and Strawberry haemangioma. With available fluence up to 108J/cm2, even Seborrhoeic Keratoses have been successfully treated with the Specialist handpiece.
Based on clinical evidence on the efficacy of blue and red light for the treatment of acne, Energist has introduced a dedicated handpiece delivering both 415nm and 630-950nm together. This maximises the photodynamic mechanism for optimum anti-bacterial and anti-inflammatory effects.
Variable Pulsed Light is a safe and effective technology for treatment of unwanted hair and skin imperfections. Clinically proven to effectively treat unwanted hair, acne, rosacea, thread veins, fine lines/wrinkles, and the visible signs of sun damage, VPL™ treatments leave your skin looking smooth, silky and radiant. The variable pulses of light emitted from the VPL™ effectively treat and remove unwanted hair and skin imperfections safely and easily, with none of the discomfort of invasive and/or surgical treatments. Variable pulsed light ensures controlled absorption of light by the target chromophore whilst minimising heating of the surrounding tissue. Each light pulse consists of a sequence of rapid micro-pulses. The number, duration and frequency of micro pulses can be adapted on the ‘pulse design screen’, to suit each patient, ensuring optimum treatment results are achieved every time, even on darker skin tones.
All UltraPlus handpieces employ dual filtering technology to remove both the shorter, more harmful wavelengths, and also the longer wavelengths which are absorbed in water and cause non-specific heating of tissue. This reduces pain and minimises side effects, enabling you to deliver more energy safely to tissue, and so provide comfortable and more effective treatment.
|Output Energy||10 to 108J/cm2|
|Handpieces||Hair removal 610-950nm output Skin rejuvenation 530-950nm output Optional Handpieces: Acne – 415/630-950nm output (Multi-bandpass dichroic filter) Specialist HE 530-950nm output|
|Pulse train length||7 to 385ms|
|Pulses per train||2 to 15|
|Delay between pulses||1 to 20ms|
|Standard spot size||50 x 10mm (5cm2)|
|Repetition rate||1 pulse every 2 seconds (max)|
|Dimensions||950 x 430 x 420mm|
|Power supply||100V to 240V, 60/50hz, Max 6.5A|
IPL Energy / Wavelength 530-950nm is indicated for the treatment of: mild to moderate inflammatory Acne Vulgaris, benign pigmented epidermal and cutaneous lesions including warts, scars and striae, benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, Poikiloderma of Civatte, leg veins, facial veins and venous malformations.
IPL Energy / Wavelength 610-950nm is indicated for the treatment of: removal of unwanted hair from all skin types and to effect stable long- term or permanent T1 hair reduction in skin types I – V through selective targeting of melanin inhair follicles.
IPL Energy / Wavelength 415/630-950nm is indicated for the treatment of: mild to moderate inflammatory Acne Vulgaris.
FDA Indications for use statement reference K082825